Lianluo Smart Ltd  

(Public, NASDAQ:LLIT)   Watch this stock  
Find more results for NASDAQ:DHRM
1.50
0.00 (0.07%)
Dec 2 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.50 - 1.59
52 week 0.79 - 3.50
Open 1.59
Vol / Avg. 0.00/38,312.00
Mkt cap 26.01M
P/E     -
Div/yield     -
EPS -2.12
Shares 17.31M
Beta 2.38
Inst. own 0%

Key stats and ratios

Q2 (Jun '16) 2015
Net profit margin -136.07% -519.26%
Operating margin -137.24% -536.24%
EBITD margin - -489.39%
Return on average assets -133.70% -39.12%
Return on average equity -407.33% -59.97%
Employees 107 -
CDP Score - -

Address

Suite 501 Jiuzhou Plaza, 83 Fuxing Road,
BEIJING, BEJ 100856
China
+86-10-51660080 (Phone)
+86-10-68416311 (Fax)

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Lianluo Smart Ltd, formerly Dehaier Medical Systems Limited, distributes and provides after-sale services for medical equipment in China through its subsidiary, Beijing Dehaier Medical Technology Co. Limited (BDL), and its affiliate, Beijing Dehaier Technology Limited (BTL). The Company, through its subsidiaries and affiliate, distributes branded medical equipment, such as sleep apnea machines, ventilator air compressors, Color Dopller Imaging Machine and laryngoscope. It also has the distribution rights for a range of international medical equipment suppliers for products, including ventilator, Color Dopller Imaging Machine, laryngoscope, sleep apnea machines and other medical equipment accessories. The Company develops and distributes medical devices focusing primarily on sleep respiratory solutions to obstructive sleep apnea syndrome (OSAS). Its distribution offerings are medical equipment used in the operating room, the intensive care unit (ICU) and the emergency room.

Officers and directors

Zhitao He Chairman of the Board
Bio & Compensation  - Reuters
Ping Chen Chief Executive Officer, Director
Age: 49
Bio & Compensation  - Reuters
Hui Zhou Chief Financial Officer
Bio & Compensation  - Reuters
Zhiqiang Chang Independent Director
Bio & Compensation  - Reuters
Bin Pan Independent Director
Bio & Compensation  - Reuters
Mingwei Zhang Independent Director
Age: 59
Bio & Compensation  - Reuters